688336 Sunshine Guojian Pharmaceutical
- 19.16
- -0.06-0.31%
Sunshine Guojian Pharmaceutical News
Sansheng Guojian: Announcement on the completion of the election of the Board of Directors and the Board of Supervisors and the appointment of senior management and securities affairs representatives
Legal Opinion of Guohao Law Firm (Shanghai) on the 2024 Third Extraordinary General Meeting of Shareholders of Sansheng Guojian Pharmaceutical (Shanghai) Co., Ltd.
Sansheng Guojian: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Kokuken Mitsubo: Announcement on the Election of Employee Representatives and Supervisors
Sansheng Guojian: Announcement on receiving dividends from participating companies
Sansheng Guojian: 2024 Third Extraordinary General Meeting of Shareholders Meeting Information
Sunshine Guojian Pharmaceutical: Notice on convening the third extraordinary shareholder meeting in 2024.
Sunshine Guojian Pharmaceutical: Announcement regarding the election of the board of directors and the board of supervisors.
Sunshine Guojian Pharmaceutical: Announcement regarding the voluntary disclosure of clinical trial results for the humanized anti-IL-17A monoclonal antibody injection (SSGJ-608) for the treatment of moderate to severe plaque psoriasis in Phase III, achieving all efficacy endpoints.
Legal opinion of Guohao Law Firm (Shanghai) on the second extraordinary general meeting of shareholders of Sunshine Guojian Pharmaceutical Co., Ltd. in 2024.
Sunshine Guojian Pharmaceutical: Announcement of resolution of the Second Extraordinary Shareholders' Meeting in 2024.
Sunshine Guojian Pharmaceutical: 2024 Second Interim Shareholder Meeting Documentation
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. plans to transfer part of its holding in the research and development pipeline of candidate drugs to Shenyang 3sbio Co., Ltd., which involves the valuation report of the assets related to the exclusive commercialization rights in the Greater China region.
Sunshine Guojian Pharmaceutical: Announcement Regarding the Cancellation of Unassigned 2021 Restricted Stocks
Sunshine Guojian Pharmaceutical: Notice Regarding the Holding of the Second Extraordinary Shareholders' Meeting in 2024.
Sunshine Guojian Pharmaceutical: 2023 Annual General Meeting of Shareholders Legal Opinions
Sunshine Guojian Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Sunshine Guojian Pharmaceutical: 2023 Annual General Meeting of Shareholders Meeting Materials
Sansei Guojian: Notice on Convening the 2023 Annual General Meeting of Shareholders
Sansheng Guojian: Announcement on holding the 2023 Annual Results and Cash Dividend Briefing
Analysis
Price Target
No Data
No Data